← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
AMREP revenue slipped, but net income and margins rose sharply, debt fell, and insiders bought nearly $878K.
The read at a glance✓ Audited against SEC data
- Business mix — Land development and home buildingNote
- Revenue — Revenue fell 3.3%Watch
- Profit — Net income rose 90.1%OK
- Cash — Free cash flow fell 5.8%Watch
- Balance sheet — Debt fell; equity rose 10.1%OK
- Insiders — 16 buys / 0 sellsOK
- Accounting — Altman-Z, Beneish-M, and earnings-quality unavailableNote
Business
AMREP is a real-estate company with Land Development and Home Building segments, concentrated around land and home sales.
Where the revenue comes from
Fiscal 2026, as AMREP CORP. reports it. History and quarterly detail are in the app.
- Land Development$29.2M
- Homebuilding$23.6M
Leadership changes
From AMREP CORP.'s own filings, the day they're filed.
- Timothy S. McNaney · director · appointmenteff. 2026-01-27
- Adrienne M. Uleau · Chief Financial Officer · appointmenteff. 2025-07-17
- Timothy McNaney · President · departure
Latest filings
- 10-K · Annual report2026-07-24
- 8-K · Company announcement2026-07-24
- 8-K · Company announcement2026-07-14
- 8-K · Company announcement2026-03-12
- 10-Q · Quarterly report2026-03-12
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- Main tension🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about AMREP CORP., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.